Abatacept in B7-1-positive proteinuric kidney disease

New England Journal of Medicine

Volumn 370, Issue 13, 2014, Pages 1263-

  Alachkar, Nada ^a   Carter Monroe, Naima ^a   Reiser, Jochen ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; B7 ANTIGEN; BETA1 INTEGRIN; RITUXIMAB; ANTIBODY CONJUGATE; BELATACEPT; IMMUNOGLOBULIN G;

ANTIGEN EXPRESSION; CELL DAMAGE; DRUG RESPONSE; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY BIOPSY; LETTER; PLASMAPHERESIS; PODOCYTE; PRIORITY JOURNAL; TREATMENT FAILURE; FEMALE; MALE; METABOLISM; NOTE; ANTIGEN DETECTION; CLINICAL EFFECTIVENESS; DRUG EFFICACY; FLUORESCENCE ANALYSIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHRECTOMY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PROTEINURIA;

ANTIGENS, CD80; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOCONJUGATES; MALE;

EID: 84897008267     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1400502     Document Type: Letter

References (1)

1. Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004;113:1390-7. (Pubitemid 39071694)